AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,113,700 | -9.9% | 45,960 | -31.8% | 0.01% | -11.1% |
| Q2 2022 | $2,345,000 | +158.5% | 67,410 | +73.0% | 0.01% | +200.0% |
| Q4 2021 | $907,000 | -61.2% | 38,958 | -69.5% | 0.00% | -62.5% |
| Q1 2021 | $2,338,000 | +13.2% | 127,622 | +24.2% | 0.01% | +14.3% |
| Q4 2020 | $2,066,000 | -0.8% | 102,726 | -7.5% | 0.01% | -12.5% |
| Q3 2020 | $2,082,000 | -12.0% | 111,028 | +5.4% | 0.01% | -20.0% |
| Q2 2020 | $2,365,000 | – | 105,290 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Campbell & CO Investment Adviser LLC | 11,961 | $219,000 | 0.13% |
| FEDERATED HERMES, INC. | 3,441,367 | $63,046,000 | 0.12% |
| CORNERCAP INVESTMENT COUNSEL INC | 54,751 | $1,003,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 34,425 | $631,000 | 0.10% |
| First Trust Direct Indexing L.P. | 11,913 | $218,000 | 0.06% |
| Summit Global Investments | 47,546 | $871,000 | 0.06% |
| WINTON GROUP Ltd | 49,766 | $912,000 | 0.05% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 397,950 | $7,290,000 | 0.05% |
| AIGEN INVESTMENT MANAGEMENT, LP | 16,077 | $295,000 | 0.04% |
| EXCHANGE TRADED CONCEPTS, LLC | 52,334 | $959,000 | 0.04% |